mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |